Timcodar is a macrolide compound that significantly inhibits lipid accumulation during adipogenesis, with efficacy comparable to rapamycin, but without causing immunosuppression or glucose resistance. It effectively suppresses the adipogenic transcription factors PPARγ and C/EBPα, thereby inhibiting the expression of genes involved in lipid accumulation. These properties support its potential application as an anti-obesity therapeutic agent.